You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Popup

Request a contact

Stay informed

Prescribe Avamys once daily 1

For adults and adolescents from 12 years of age: 2 sprays per nostril once daily 2

For children aged 2 to 11 years: 1 spray per nostril once daily 2

Download full Prescribing Information for Avamys

A modern delivery system 3–6

In a preference study with FPNS, the overall incidence of AEs with FF was 2%, or 3 events: dizziness, headache, nasal congestion. 6

How to use the Avamys device

Watch the video to find out more

Differences between FFNS and MFNS devices

Watch the video to find out more

AE: adverse event; AR: allergic rhinitis; FFNS: fluticasone furoate nasal spray; FPNS: fluticasone propionate nasal spray; MFNS: mometasone furoate nasal spray.

References

  1. Vasar M, Houle PA, Douglass JA, et al. Fluticasone furoate nasal spray: Effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents. Allergy Asthma Proc. 2008;29(3):313–321.
  2. Fluticasone Furoate Global Data Sheet; version 11, 03 April 2018.
  3. Berger WE, Godfrey JW, Slater AL. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance. Expert Opin Drug Deliv. 2007;4(6):689–701.
  4. Berger WE, Godfrey JW, Grant AC, et al. Fluticasone furoate (FF) nasal spray: development of a next-generation delivery system for allergic rhinitis [abstract no. 907]. J Allergy Clin Immunol. 2007;119:S231.
  5. Godfrey JW, Grant AC, Slater AL. Fluticasone Furoate (FF) Nasal spray-ergonomic considerations for a next generation delivery system. J Allergy Clin lmmunol. 2007;119(Suppl. 1):S230.
  6. Meltzer EO, Stahlman JE, Leflein J, et al. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study. Clin Ther. 2008;30(2):271–279.

Avamys is a registered trademark of the GlaxoSmithKline group of companies